Lista de obras - Stéphane Terry - Dominio Público Uruguay

A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.

artículo científico publicado en 2005

AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity

artículo científico publicado en 2019

Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity.

artículo científico publicado en 2017

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment

artículo científico publicado en 2021

Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cells.

artículo científico publicado en 2012

Cancer stem-like cells evade CD8+CD103+ tumor-resident memory T (TRM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model

artículo científico publicado en 2022

Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

artículo científico publicado en 2010

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer

artículo científico publicado en 2015

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells.

artículo científico publicado en 2006

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance

artículo científico publicado en 2012

Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing

artículo científico publicado en 2010

Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling.

artículo científico publicado en 2017

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.

artículo científico publicado en 2010

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

artículo científico publicado en 2015

Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

artículo científico publicado en 2016

Increased expression of class III beta-tubulin in castration-resistant human prostate cancer

artículo científico publicado en 2009

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

artículo científico publicado en 2009

Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners.

artículo científico publicado en 2014

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

artículo científico publicado en 2011

Neuroendocrine differentiation in prostate cancer: from lab to bedside

artículo científico publicado en 2007

New insights into the role of EMT in tumor immune escape.

artículo científico publicado en 2017

Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium

artículo científico publicado en 2012

Oncogene-mediated alterations in chromatin conformation

artículo científico publicado en 2012

Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life.

artículo científico publicado en 2009

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy

artículo científico publicado en 2012

Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance

scientific article published on 08 December 2010

Protocadherin-PC promotes androgen-independent prostate cancer cell growth.

artículo científico publicado en 2006

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial

artículo científico publicado en 2013

Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity

artículo científico publicado en 2018

The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?

artículo científico publicado en 2007

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.

artículo científico publicado en 2017

The many faces of neuroendocrine differentiation in prostate cancer progression

artículo científico publicado en 2014

The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance

artículo científico publicado en 2011

Lista de obras de Stéphane Terry

A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.

AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity

Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity.

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment

Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cells.

Cancer stem-like cells evade CD8<sup>+</sup>CD103<sup>+</sup> tumor-resident memory T (T<sub>RM</sub>) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model

Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells.

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance

Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing

Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling.

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

Increased expression of class III beta-tubulin in castration-resistant human prostate cancer

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners.

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

Neuroendocrine differentiation in prostate cancer: from lab to bedside

New insights into the role of EMT in tumor immune escape.

Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium

Oncogene-mediated alterations in chromatin conformation

Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life.

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy

Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance

Protocadherin-PC promotes androgen-independent prostate cancer cell growth.

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial

Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity

The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.

The many faces of neuroendocrine differentiation in prostate cancer progression

The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance